CPHI 2022 - Trends, challenges & opportunities

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses emerging trends and challenges for the life sciences sector live from CPHI Frankfurt 2022, with: Grainne Hughes, Vice President of Business Support Operations at Almac  Christine Fürst, Senior Director Key Account Manager Europe at Vetter Pharma  Guido Wallraff, Corporate Business Development Director at Ardena Jenny Gattari, CDMO Business Development Lead (North America) at Pfizer CentreOne  Brittany Hayes, Director of Global Highly Potent & Oncology Platform at CordenPharma Listen to this episode to find out more about these companies and gain an insight into the changes and demands they see coming in 2023. They also discuss their experience of CPHI this year, how it compares to last year’s event and what trends they have noticed across their exploration of the Messe.  Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!  Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.